Robuta

https://www.mdanderson.org/newsroom/archived-news/md-anderson-cancer-c.h00-159069501.html ARCHIVED: MD Anderson & Adaptimmune partner to advance development of immunotherapies targeting... Adaptimmune Therapeutics and The University of Texas MD Anderson Cancer Center announced today they have entered into a multi-year strategic alliance designed... md andersonarchivedadaptimmunepartner https://www.nayatx.com/ Home | NAYA Therapeutics: Pioneering the Next Generation of Cancer Immunotherapies NAYA Therapeutics: Pioneering the Next Generation of Cancer Immunotherapies the next generationnayatherapeuticspioneeringcancer https://hochschul-job.de/job/postdoctoral-research-associate-on-investigation-of-immunotherapies-at-the-nanoscale-2/ Postdoctoral Research Associate on Investigation of Immunotherapies at the Nanoscale -... postdoctoral researchat theassociateinvestigationimmunotherapies https://pubmed.ncbi.nlm.nih.gov/28427519/ A comprehensive review of immunotherapies in prostate cancer Prostate cancer is the second most common malignant neoplasm in men worldwide and the fifth cause of cancer-related death. Although multiple new agents have... comprehensive reviewimmunotherapiesprostatecancer https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2022.953312/full Frontiers | Editorial: Breakthroughs in immunotherapies and precision treatment against infectious... A variety of new and reemerging pathogenic organisms, including bacteria, viruses, parasites, and fungi, have a great influence on public health worldwide. N... precision treatmentfrontierseditorialbreakthroughsimmunotherapies https://www.asbmb.org/asbmb-today/science/012320/early-immune-response-may-improve-cancer-immunothe Early immune response may improve cancer immunotherapies University of Illinois at Chicago researchers and colleagues report a new mechanism for detecting foreign material during early immune responses. immune responseearlymayimprovecancer https://www.fool.com/investing/2020/05/04/can-this-biotech-shed-new-light-on-cancer-immunoth.aspx Can This Biotech Shed New Light on Cancer Immunotherapies? | The Motley Fool May 4, 2020 - Its new discovery in the field of cancer immunotherapy produced mixed clinical results, but it certainly has ample backing from the big players. new light https://www.agenusbio.com/ Agenus: Better immunotherapies Activating the Power of the Immune System to Defeat Cancer betterimmunotherapies https://haemalogix.com/ HaemaLogiX | Next-Gen Immunotherapies for Multiple Myeloma (KMA & LMA) next genmultiple myelomaimmunotherapieskmalma https://www.coding.bio/ Coding Bio | Engineering Modular Immunotherapies Coding Bio unites a high throughput wet lab and ML platform to screen, build, and deliver fully-assembled modular therapies like CARs and BiTEs in only months. bio engineeringcodingmodularimmunotherapies https://www.biopharmadive.com/news/merck-discontinue-vibostolimab-favezelimab-TIGIT-LAG3/735714/ Merck calls quits on two immunotherapies for cancer | BioPharma Dive The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 testing. merckcallstwoimmunotherapiescancer https://elicio.com/ Lymph Node-Targeted Immunotherapies | Elicio Therapeutics Elicio is a clinical-stage biotechnology company harnessing the power of the lymph nodes to amplify the immune response in the fight against cancer. lymph nodetargetedimmunotherapiestherapeutics https://www.ai-therapies.com/ Ananda Immunotherapies anandaimmunotherapies https://news.mit.edu/2024/blueprint-better-cancer-immunotherapies-1125 A blueprint for better cancer immunotherapies | MIT News | Massachusetts Institute of Technology MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments. for better https://www.ygion.bio/ YGION Biomedical – Individualized Immunotherapies Against Cancer Jun 29, 2026 - Advancing healthcare through targeted immunotherapies Learn more about our pipeline At YGION, we harness the power of the body's own immune system to trigger... biomedicalindividualizedimmunotherapiescancer https://www.sintef.no/en/publications/publication/0198cc4fb067-d79ecf6e-98ad-4b85-afe9-24edeea26e0b/ Miniaturization of bioprocess development for immunotherapies - SINTEF bioprocess developmentminiaturizationimmunotherapiessintef https://www.replimune.com/ Oncolytic Immunotherapies | Replimune Aug 6, 2026 - Replimune is a commercial-stage biotech company revolutionizing cancer treatment with a new class of oncolytic immunotherapies designed to activate a… immunotherapiesreplimune https://pmc.ncbi.nlm.nih.gov/articles/PMC5096828/ Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies -... Potent CD19-directed immunotherapies, such as chimeric antigen receptor T cells (CART) and blinatumomab, have drastically changed the outcome of patients with... https://www.geneostx.com/ Geneos Therapeutics - Exquisitely Personalized Immunotherapies Jun 22, 2026 - Bringing Personalized Immunotherapies for Cancer to the world, one patient at a time. Geneos Therapeutics, a Phase 2b biotherapeutics company, is developing... geneostherapeuticspersonalizedimmunotherapies https://cimcure.com/ CimCure – Cancer Immunotherapies What we do CimCure is an international biotech company that develops cancer vaccines which directly target and destroy the tumour’s network of blood vessels so... cancerimmunotherapies https://www.prnewswire.co.uk/news-releases/research-and-markets---global-cancer-immunotherapies-market-2016-2020---key-vendors-are-amgen-bristol-myers-squibb--merck-578761061.html Research and Markets - Global Cancer Immunotherapies Market 2016-2020 - Key Vendors are Amgen,... /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cancer Immunotherapies Market 2016-2020" report to their offering. (Logo:... https://www.haptena.com/ Haptena Therapeutics | Targeted immunotherapies Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering. Our research... therapeuticstargetedimmunotherapies https://www.lynx.bio/ Home | Lynx Bio | Multi-Omic Platform for Immunotherapies LynxBio is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep... lynxbiomultiomicplatform https://www.mdc-berlin.de/news/news/path-new-immunotherapies-clinic The path of new immunotherapies to the clinic | Max Delbrück Center Bringing a new CAR-T cell therapy from promising results in the lab to critically ill cancer patients is anything but straightforward. A Tagesspiegel podcast... the pathnewimmunotherapiesclinicmax https://www.prnewswire.com/news-releases/global-immunotherapy-drugs-markets-2021-2026---launch-of-ng-immunotherapies--covid-19-as-growth-catalyst--approval-of-novel-immunotherapy-drugs--surge-in-adoption-of-car-t-cell-therapies-301410944.html Global Immunotherapy Drugs Markets 2021-2026 - Launch of NG Immunotherapies / COVID-19 as Growth... https://i4id.org/ Home - Immunotherapies & Innovations for Infectious Diseases Congress | I4ID infectious diseases congressimmunotherapiesinnovations https://pubs.rsc.org/en/content/articlelanding/2023/cs/d2cs00928e Smart probes for optical imaging of T cells and screening of anti-cancer immunotherapies - Chemical... T cells are an essential part of the immune system with crucial roles in adaptive response and the maintenance of tissue homeostasis. Depending on their... https://seas.harvard.edu/news/seas-developed-cancer-immunotherapies-be-commercialized-novartis SEAS-developed cancer immunotherapies to be commercialized by Novartis Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development to beseasdevelopedcancerimmunotherapies https://sciencedaily.com/releases/2023/04/230404114202.htm Jumping genes in cancer cells open door to new immunotherapies | ScienceDaily New research suggests that transposable elements in various cancers potentially may be used to direct novel immunotherapies to tumors that don't typically... jumping genescancer cellsopen door https://klabtx.com/ K-Lab Therapeutics — Cancer Immunotherapies K-Lab Therapeutics — a biotech startup developing novel immunotherapies targeting MDSCs and cancer cells to treat advanced and metastatic cancers. klabtherapeuticscancerimmunotherapies https://education.uwmedicine.org/blog/specialty_faculty/immunity-and-immunotherapies/ Immunity and Immunotherapies Archives - UWSOM Intranet immunityimmunotherapiesarchivesintranet https://www.fiercebiotech.com/biotech/asher-bio-sets-out-55m-to-deliver-pros-cytokines-and-other-immunotherapies-without-cons Asher Bio sets out with $55M to deliver the pros of cytokines, other immunotherapies without the... Mar 23, 2021 - There is no shortage of companies working to deliver the therapeutic benefits of cytokines without their nasty side effects, from Synthekine and Nektar... https://convention.bio.org/participating-companies/etherna-immunotherapies eTheRNA immunotherapies - BIO International Convention 2026 bio international conventionethernaimmunotherapies